Overview

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the management of inflammation following ocular surgery.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sirion Therapeutics, Inc.
Treatments:
Difluprednate
Fluprednisolone
Criteria
Inclusion Criteria:

- Scheduled for unilateral ocular surgery.

Exclusion Criteria:

- Systemic administration of any corticosteroid or immunosuppressive drug in the 2 weeks
prior to study enrollment.